Fate Operating Income from 2010 to 2024
| FATE Stock | USD 3.95 0.09 2.23% |
Operating Income | First Reported 2011-12-31 | Previous Quarter -51.3 M | Current Value -48.1 M | Quarterly Volatility 23.8 M |
Check Fate Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fate main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 7.1 M or Selling General Administrative of 85.5 M, as well as many exotic indicators such as Price To Sales Ratio of 5.5, Dividend Yield of 0.06 or PTB Ratio of 0.95. Fate financial statements analysis is a perfect complement when working with Fate Therapeutics Valuation or Volatility modules.
Fate | Operating Income |
Latest Fate Therapeutics' Operating Income Growth Pattern
Below is the plot of the Operating Income of Fate Therapeutics over the last few years. Operating Income is the amount of profit realized from Fate Therapeutics operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Fate Therapeutics is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Fate Therapeutics' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fate Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Fate Operating Income Regression Statistics
| Arithmetic Mean | (90,147,830) | |
| Coefficient Of Variation | (101.15) | |
| Mean Deviation | 74,619,529 | |
| Median | (42,125,000) | |
| Standard Deviation | 91,180,872 | |
| Sample Variance | 8314T | |
| Range | 295.1M | |
| R-Value | (0.85) | |
| Mean Square Error | 2528.6T | |
| R-Squared | 0.72 | |
| Significance | 0.000067 | |
| Slope | (17,271,261) | |
| Total Sum of Squares | 116395.3T |
Fate Operating Income History
Other Fundumenentals of Fate Therapeutics
Fate Therapeutics Operating Income component correlations
Click cells to compare fundamentals
About Fate Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fate Therapeutics income statement, its balance sheet, and the statement of cash flows. Fate Therapeutics investors use historical funamental indicators, such as Fate Therapeutics's Operating Income, to determine how well the company is positioned to perform in the future. Although Fate Therapeutics investors may use each financial statement separately, they are all related. The changes in Fate Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fate Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fate Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fate Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | -177.6 M | -168.7 M | |
| Non Operating Income Net Other | 4.4 M | 4.6 M |
Fate Therapeutics Investors Sentiment
The influence of Fate Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Fate. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Fate Therapeutics' public news can be used to forecast risks associated with an investment in Fate. The trend in average sentiment can be used to explain how an investor holding Fate can time the market purely based on public headlines and social activities around Fate Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Fate Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Fate Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Fate Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Fate Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fate Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fate Therapeutics' short interest history, or implied volatility extrapolated from Fate Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Fate Therapeutics Correlation against competitors. For information on how to trade Fate Stock refer to our How to Trade Fate Stock guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Fate Stock analysis
When running Fate Therapeutics' price analysis, check to measure Fate Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fate Therapeutics is operating at the current time. Most of Fate Therapeutics' value examination focuses on studying past and present price action to predict the probability of Fate Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fate Therapeutics' price. Additionally, you may evaluate how the addition of Fate Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Fate Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fate Therapeutics. If investors know Fate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share 0.646 | Quarterly Revenue Growth (0.96) | Return On Assets (0.18) | Return On Equity (0.38) |
The market value of Fate Therapeutics is measured differently than its book value, which is the value of Fate that is recorded on the company's balance sheet. Investors also form their own opinion of Fate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fate Therapeutics' market value can be influenced by many factors that don't directly affect Fate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.